|Bid||107.36 x 3100|
|Ask||107.38 x 1400|
|Day's Range||106.43 - 110.28|
|52 Week Range||72.13 - 122.15|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||32.98|
|Earnings Date||Nov 24, 2020|
|Forward Dividend & Yield||2.32 (2.08%)|
|Ex-Dividend Date||Sep 24, 2020|
|1y Target Est||117.17|
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for the Abre™ venous self-expanding stent system. This device is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction, also known as deep venous obstruction.
West Pharmaceutical reviewed its compliance and ethics program last year so well that a key ESG ratings firm upgraded it to the highest-possible AAA grade, just as WST stock hit new highs.
ISRG stock has risen this year, but Intuitive Surgical stock so far sees only a partial recovery from the Covid-19 pandemic. So, is it time to take on this robotic surgery stock?